Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Research output: Contribution to journal › Article › peer-review
44Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial'. Together they form a unique fingerprint.